title: Nanotherapeutics for autoimmunity becomes mainstream.
authors.affiliation: Institute of Cellular Therapeutics, Allegheny Health Network, Pittsburgh, PA, USA. Electronic address: ngiannou@wpahs.org.
authors.forename: Nick
authors.initials: N
authors.lastname: Giannoukakis
authors.affiliation: Division of Pharmaceutical Sciences, Mylan School of Pharmacy, Duquesne University, Pittsburgh, PA, USA. Electronic address: meng@duq.edu.
authors.forename: Wilson S
authors.initials: WS
authors.lastname: Meng
mesh_terms: D001327:Autoimmune Diseases / Q000628:therapy*; D015551:Autoimmunity; D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans; D050997:Nanomedicine / Q000379:methods* / Q000639:trends*